Malmö-based Medbeat, founded by Erik Rask, recently secured € 135.000 from three investors on SVT’s Draknästet, the Swedish version of Dragons Den, valuing the company at over € 7 million (84 million SEK). Medbeat offers a wearable ECG device, allowing clinics to monitor patients effectively. The investment exceeded Rask’s initial request of 1 million SEK for a 1% stake but resulted in a lower valuation than sought.
The appearance generated significant interest, with many healthcare facilities reaching out afterwards according to an interview by Rapidus.
“We hope more hear about us now, so even more patients can get faster care.”
Erik Rask said
In 2023, Medbeat had € 500.000 (6 million SEK) in revenue with sales growing in 2024. Erik highlights their quick sales processes, contributing to faster growth compared to other medtech companies.
Medbeat plans to start collaborating with the investors this fall, using the investment to expand its market presence and continue developing its innovative healthcare solutions.
